Good News for Early HER2+ Patients - SHARE Metastatic ...

SHARE Metastatic Breast Cancer

6,770 members8,366 posts

Good News for Early HER2+ Patients

Hazelgreen profile image
1 Reply

nature.com/articles/s41523-...

This article indicates that 95% of early HER2+ patients live at least 5 years after diagnosis. This was a follow-up study to an original predictive model which suggested an 88% survival rate. I thought some of you with HER2+ mets might be interested in reviewing the details.

Written by
Hazelgreen profile image
Hazelgreen
To view profiles and participate in discussions please or .
1 Reply
Nature613 profile image
Nature613

Hi Hazelgreen,

Thanks for posting this. Best wishes to you.

Not what you're looking for?

You may also like...

Good News for HER2 Positive MBC Patients!

If your cancer is HER2 positive and you’ve already had one or more HER2-directed therapies for...

HER2- changed to HER2+

Hello breasties, So, the first treatment of MBC which was Ibrance and Letrozole stopped working...

FDA-Approved Treatments for HER2+, Hormone Receptor Negative Patients

This is the third in a series about FDA-approved treatments for each sub-type of MBC. Next week...

Change from HER2 negative to HER2 positive?

Has anyone had a change from HER2 negative to HER2 positive? Taking Ibrance 100mg\\monthly...

Good news? Maybe.

The investigational anti-body drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd) was associated...